IMPAX LABS FDA Approval ANDA 086212

ANDA 086212

IMPAX LABS

FDA Drug Application

Application #086212

Application Sponsors

ANDA 086212IMPAX LABS

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL25MG0CHLORDIAZEPOXIDE HYDROCHLORIDECHLORDIAZEPOXIDE HYDROCHLORIDE

FDA Submissions

ORIG1AP1979-07-10
LABELING; LabelingSUPPL2AP1989-10-24
LABELING; LabelingSUPPL3AP1991-02-04
LABELING; LabelingSUPPL4AP1991-02-04
LABELING; LabelingSUPPL5AP1991-09-17
LABELING; LabelingSUPPL6AP1991-10-24
LABELING; LabelingSUPPL7AP1992-01-14

CDER Filings

IMPAX LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 86212
            [companyName] => IMPAX LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"CHLORDIAZEPOXIDE HYDROCHLORIDE","activeIngredients":"CHLORDIAZEPOXIDE HYDROCHLORIDE","strength":"25MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CHLORDIAZEPOXIDE HYDROCHLORIDE","submission":"CHLORDIAZEPOXIDE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.